BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33083484)

  • 1. JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma.
    Meng L; Ding L; Yu Y; Li W
    Biomed Res Int; 2020; 2020():7973568. PubMed ID: 33083484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TYK2 is a prognostic biomarker and associated with immune infiltration in the lung adenocarcinoma microenvironment.
    He A; Zhang R; Wang J; Huang Z; Liao W; Li Y; Wang C; Yang J; Feng Q; Wu L
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e129-e140. PubMed ID: 33852776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
    Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
    Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma.
    Guo L; Fang T; Jiang Y; Liu D
    Int J Gen Med; 2021; 14():9887-9902. PubMed ID: 34938108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
    Guo L; Liu D
    Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma.
    Liang F; Liang H; Li Z; Huang P
    Int Immunopharmacol; 2020 Sep; 86():106706. PubMed ID: 32570038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Bioinformatic Analysis of NOTCH Pathway Involvement in Stomach Adenocarcinoma.
    Xue D; Li D; Dou C; Li J
    Dis Markers; 2021; 2021():4739868. PubMed ID: 34925644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased ANXA5 expression in stomach adenocarcinoma infers a poor prognosis and high level of immune infiltration.
    Su Z; Shu K; Li G
    Cancer Biomark; 2022; 35(2):155-165. PubMed ID: 35912732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition.
    Lupardus PJ; Ultsch M; Wallweber H; Bir Kohli P; Johnson AR; Eigenbrot C
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8025-30. PubMed ID: 24843152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
    Zhou F; Lin Q; Zheng Z
    Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immune checkpoint inhibitors and biomarkers among STAT family in stomach adenocarcinoma.
    Guo L; Fang T; Jiang Y; Liu D
    Am J Transl Res; 2020; 12(9):4977-4997. PubMed ID: 33042401
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of arsenic trioxide and 5-aza-2'-deoxycytidine on SHP-1, JAK3, TYK2 gene expression in K562 cells].
    Zhang XK; Luo JM; Sun J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):323-8. PubMed ID: 24762999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASF1B acted as a prognostic biomarker for stomach adenocarcinoma.
    Zhao C; Zhou J; Xing J; Yin Q
    Medicine (Baltimore); 2023 Dec; 102(48):e35408. PubMed ID: 38050219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma.
    Zhang J; Hou W; Zuo J; Huang Z; Ding X; Bu X
    Medicine (Baltimore); 2022 Oct; 101(42):e31096. PubMed ID: 36281171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma.
    Huang Z; He A; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Aging (Albany NY); 2021 Jun; 13(12):16637-16655. PubMed ID: 34162762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma.
    Guo Y; Wang ZW; Su WH; Chen J; Wang YL
    Biomed Res Int; 2020; 2020():4145164. PubMed ID: 32685482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
    Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
    Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.